FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
A year after the overturning of Roe v. Wade, many physicians and hospitals in the states that have restricted abortion
Read MoreSACRAMENTO, Calif. — A mountain of evidence shows police often fail to respond properly to people experiencing a mental health crisis.
Read MoreA vial and a medical syringe seen displayed in front of the US Food and Drug Administration and Moderna biotechnology
Read MoreADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to
Read MoreAs the nation’s top health official and leader of one of the federal government’s largest departments, the secretary of Health
Read MoreHealthDay News — Increased hospitalizations involving fungal infections were identified during the COVID-19 pandemic, according to a study published in
Read MoreSource/Disclosures Disclosures: Korczak reports receiving funding from the Canadian Institutes of Health Research, Ontario Ministry of Health SickKids Foundation and
Read MoreOrthorexia nervosa is “an unrecognized psychological eating disorder in which the person becomes obsessed with eating pure, healthy and right
Read MoreA health worker prepares a flu vaccine shot before administering it to a local resident in Los Angeles, the United
Read MoreAs maternal mortality skyrockets in the United States, a federal program created to improve rural maternity care has bypassed Black
Read More